Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Morten Frödin"'
Publikováno v:
BMC Biotechnology, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background The ability of CRISPR/Cas9 to mutate any desired genomic locus is being increasingly explored in the emerging area of cancer immunotherapy. In this respect, current efforts are mostly focused on the use of autologous (i.e. patient
Externí odkaz:
https://doaj.org/article/3ccd4e8d15fd4f5285b195df9b4fe5f8
Autor:
Mette Nyegaard, Nanna D Rendtorff, Morten S Nielsen, Thomas J Corydon, Ditte Demontis, Anna Starnawska, Anne Hedemand, Annalisa Buniello, Francesco Niola, Michael T Overgaard, Suzanne M Leal, Wasim Ahmad, Friedrik P Wikman, Kirsten B Petersen, Dorthe G Crüger, Jaap Oostrik, Hannie Kremer, Niels Tommerup, Morten Frödin, Karen P Steel, Lisbeth Tranebjærg, Anders D Børglum
Publikováno v:
PLoS Genetics, Vol 11, Iss 7, p e1005386 (2015)
Nonsyndromic hearing impairment (NSHI) is a highly heterogeneous condition with more than eighty known causative genes. However, in the clinical setting, a large number of NSHI families have unexplained etiology, suggesting that there are many more g
Externí odkaz:
https://doaj.org/article/c3cde509dda1488686ad20653467c3ea
Autor:
Alanna C. Green, Petra Marttila, Nicole Kiweler, Christina Chalkiadaki, Elisée Wiita, Victoria Cookson, Antoine Lesur, Kim Eiden, François Bernardin, Karl S. A. Vallin, Sanjay Borhade, Maeve Long, Elahe Kamali Ghahe, Julio J. Jiménez-Alonso, Ann-Sofie Jemth, Olga Loseva, Oliver Mortusewicz, Marianne Meyers, Elodie Viry, Annika I. Johansson, Ondřej Hodek, Evert Homan, Nadilly Bonagas, Louise Ramos, Lars Sandberg, Morten Frödin, Etienne Moussay, Ana Slipicevic, Elisabeth Letellier, Jérôme Paggetti, Claus Storgaard Sørensen, Thomas Helleday, Martin Henriksson, Johannes Meiser
Cancer cells fuel their increased need for nucleotide supply by upregulating one-carbon (1C) metabolism, including the enzymes methylenetetrahydrofolate dehydrogenase-cyclohydrolase 1 and 2 (MTHFD1 and MTHFD2). TH9619 is a potent inhibitor of dehydro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cef4c9b031ee478e94f3df8742d2401f
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-206656
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-206656
Autor:
Yiyuan Niu, Hans H. Wandall, Ida Elisabeth Johansen, Morten Frödin, Christopher Aled Chamberlain, Eric P. Bennett, Özcan Met, Bent O. Petersen, Zhang Yang
Publikováno v:
Nucleic Acids Research
Bennett, E P, Petersen, B L, Johansen, I E, Niu, Y, Yang, Z, Chamberlain, C A, Met, Ö, Wandall, H H & Frödin, M 2020, ' INDEL detection, the 'Achilles heel' of precise genome editing : a survey of methods for accurate profiling of gene editing induced indels ', Nucleic Acids Research, vol. 48, no. 21, pp. 11958-11981 . https://doi.org/10.1093/nar/gkaa975
Bennett, E P, Petersen, B L, Johansen, I E, Niu, Y, Yang, Z, Chamberlain, C A, Met, Ö, Wandall, H H & Frödin, M 2020, ' INDEL detection, the 'Achilles heel' of precise genome editing : a survey of methods for accurate profiling of gene editing induced indels ', Nucleic Acids Research, vol. 48, no. 21, pp. 11958-11981 . https://doi.org/10.1093/nar/gkaa975
Advances in genome editing technologies have enabled manipulation of genomes at the single base level. These technologies are based on programmable nucleases (PNs) that include meganucleases, zinc-finger nucleases (ZFNs), transcription activator-like
Publikováno v:
Oncogene
Ouyang, H, Luong, P, Frödin, M & Hansen, S H 2020, ' p190A RhoGAP induces CDH1 expression and cooperates with E-cadherin to activate LATS kinases and suppress tumor cell growth ', Oncogene, vol. 39, no. 33, pp. 5570-5587 . https://doi.org/10.1038/s41388-020-1385-2
Ouyang, H, Luong, P, Frödin, M & Hansen, S H 2020, ' p190A RhoGAP induces CDH1 expression and cooperates with E-cadherin to activate LATS kinases and suppress tumor cell growth ', Oncogene, vol. 39, no. 33, pp. 5570-5587 . https://doi.org/10.1038/s41388-020-1385-2
The ARHGAP35 gene encoding p190A RhoGAP (p190A) is significantly altered by both mutation and allelic deletion in human cancer, but the functional implications of such alterations are not known. Here, we demonstrate for the first time that p190A is a
Autor:
Yiyuan Niu, Catarina A. Ferreira Azevedo, Xin Li, Elahe Kamali, Ole Haagen Nielsen, Claus Storgaard Sørensen, Morten Frödin
Publikováno v:
Niu, Y, Azevedo, C A F, Li, X, Kamali, E, Nielsen, O H, Sørensen, C S & Frödin, M 2022, ' Multiparametric and accurate functional analysis of genetic sequence variants using CRISPR-Select ', Nature Genetics, vol. 54 . https://doi.org/10.1038/s41588-022-01224-7
Nature Genetics
Nature Genetics
Determining the functional role of thousands of genetic sequence variants (mutations) associated with genetic diseases is a major challenge. Here we present clustered regularly interspaced short palindromic repeat (CRISPR)-SelectTIME, CRISPR-SelectSP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc6a533e3b1f731f7476b06c300e57b4
https://curis.ku.dk/ws/files/328445052/s41588_022_01224_7.pdf
https://curis.ku.dk/ws/files/328445052/s41588_022_01224_7.pdf
Publikováno v:
Kamali, E, Rahbarizadeh, F, Hojati, Z & Frödin, M 2021, ' CRISPR/Cas9-mediated knockout of clinically relevant alloantigenes in human primary T cells ', BMC Biotechnology, vol. 21, no. 1, 9 . https://doi.org/10.1186/s12896-020-00665-4
BMC Biotechnology
BMC Biotechnology, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Biotechnology
BMC Biotechnology, Vol 21, Iss 1, Pp 1-10 (2021)
Background The ability of CRISPR/Cas9 to mutate any desired genomic locus is being increasingly explored in the emerging area of cancer immunotherapy. In this respect, current efforts are mostly focused on the use of autologous (i.e. patient-derived)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71f3cd7d5b9c54a064caa460f051eb23
https://curis.ku.dk/ws/files/257031055/s12896_020_00665_4.pdf
https://curis.ku.dk/ws/files/257031055/s12896_020_00665_4.pdf
Autor:
Steen H. Hansen, Clemens P. Köllmann, Scott R. Frank, Morten Frödin, Raffaele A. Calogero, Lihua Zou, Giorgio G. Galli, Phi Luong, Gad Getz, Andre Bernards
Publikováno v:
Frank, S R, Köllmann, C P, Luong, P, Galli, G G, Zou, L, Bernards, A, Getz, G, Calogero, R A, Frödin, M & Hansen, S H 2018, ' p190 RhoGAP promotes contact inhibition in epithelial cells by repressing YAP activity ', The Journal of Cell Biology, vol. 217, no. 9, pp. 3183-3201 . https://doi.org/10.1083/jcb.201710058
ARHGAP35 encoding p190A RhoGAP is a cancer-associated gene with a mutation spectrum suggestive of a tumor-suppressor function. In this study, we demonstrate that loss of heterozygosity for ARHGAP35 occurs in human tumors. We sought to identify tumor-
Autor:
Sally Dabelsteen, Amalie Dahl Haue, Ulla Mandel, Asha M.R. Levann, Hans H. Wandall, Kirstine Lavrsen, Lars Hansen, Eric P. Bennett, Sergey Y. Vakhrushev, Morten Frödin, August Dylander
Publikováno v:
Journal of Biological Chemistry. 293:1298-1314
Aberrant expression of O-glycans is a hallmark of epithelial cancers. Mucin-type O-glycosylation is initiated by a large family of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts) that target different proteins and are differenti
Autor:
Lindsey A. Lonowski, Anjum Riaz, Steen H. Hansen, Hans H. Wandall, Katarzyna Duda, Eric P. Bennett, Elke A. Ober, Morten Frödin, Henrik Clausen, Yoshiki Narimatsu, Zhang Yang, Francesco Niola, Catherine E Delay
Publikováno v:
Nat Protoc
This protocol describes methods for increasing and evaluating the efficiency of genome editing based on the CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats-CRISPR-associated 9) system, transcription activator-like effector nucl